Immucell Corp
ICCC- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000811641
No open-market purchases or sales by Immucell Corp insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.4M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Immucell Corp changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 28 | 25 | −3 |
| Shares | 1.04M | 1.02M | −25.2K (−2.4%) |
| Value | $5.31M | $5.39M | +$83.5K (+1.6%) |
New holders (0)
Institutions that held Immucell Corp at the end of Q1 2024 but not at the end of Q4 2023.
None.
Sold out (3)
Institutions that held Immucell Corp at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Mission Wealth Management, LP | 10,000 | $50.9K |
| Advisor Group Holdings, Inc. | 550 | $2.80K |
| Northwestern Mutual Wealth Management Co | 152 | $774 |